Kura Oncology (KURA) Operating Leases (2020 - 2026)
Kura Oncology's Operating Leases was $13.37 million in Q2 2026, up 64.0% from $8.16 million a year earlier and up 1.0% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Operating Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Kura Oncology came in at $9.47 million, up 82.4% from FY2024.
- Operating Leases shows a five-year compound annual growth rate of 10.9% (FY2020 to FY2025).
- In earlier years, Operating Leases was $5.19 million in FY2024 (-18.4%), $6.36 million in FY2023 (+149.7%), $2.55 million in FY2022 (-44.8%) and $4.61 million in FY2021 (-18.2%).
- The Q2 2026 figure marks the highest quarterly Operating Leases in data going back to Q2 2020.
- Compared with a year earlier, Operating Leases has increased for six straight quarters, with growth averaging 37.5% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q2 2024 (growth of 301.6%); the worst was Q2 2023 (a decline of 59.6%).
- Per Business Quant data, KURA's Operating Leases in the three quarters before Q2 2026 was $13.24 million (Q1 2026), $9.47 million (Q4 2025) and $8.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kura Oncology | 952.70 Mn | 952.70 Mn | 20.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.37 Mn |
| Mar 31, 2026 | 13.24 Mn |
| Dec 31, 2025 | 9.47 Mn |
| Sep 30, 2025 | 8.36 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Mar 31, 2025 | 7.88 Mn |
| Dec 31, 2024 | 5.19 Mn |
| Sep 30, 2024 | 5.47 Mn |
| Jun 30, 2024 | 5.84 Mn |
| Mar 31, 2024 | 6.23 Mn |
| Dec 31, 2023 | 6.36 Mn |
| Sep 30, 2023 | 6.45 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 2.55 Mn |
| Sep 30, 2022 | 3.08 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Mar 31, 2022 | 4.11 Mn |
| Dec 31, 2021 | 4.61 Mn |
| Sep 30, 2021 | 5.10 Mn |
API Access
Kura Oncology Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();